Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE OpenBruce E. Sands, Chinyu Su, Julián Panés et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 85
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical ProgramGary R. Lichtenstein, Edward V. Loftus, Brian Bressler et al.|Inflammatory Bowel Diseases|2022Cited by 39
905 - Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis after Treatment Interruption: Results from the Octave Clinical TrialsJulián Panés, Chinyu Su, Leonardo Salese et al.|Gastroenterology|2018Cited by 6